Coronary restenosis is a medical phenomenon marked by the re-narrowing or blockage of coronary arteries subsequent to an initial medical intervention like angioplasty or the placement of a stent to address coronary artery disease. While these interventions initially succeed in restoring blood flow to the heart, the recurrence of symptoms, such as chest pain or angina, indicates the onset of restenosis. This condition is primarily attributed to the re-growth of tissue within the treated artery, referred to as neointimal hyperplasia, or the reappearance of atherosclerotic plaque. The development of coronary restenosis involves a complex interplay of factors, including patient-specific characteristics, procedural techniques employed during the initial intervention, and the types of devices used. Continuous efforts by researchers and clinicians are focused on devising strategies to mitigate the risk of restenosis. One such advancement includes the development of drug-eluting stents that release medication, aiming to inhibit excessive tissue growth in the treated arteries.
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : Empathy and precision: Revolutionizing communication between cardiologists and patients
Iris Panagiota Efthymiou, University of Greenwich, United Kingdom
Title : Ex-situ organ perfusion and cardiac performance improvement
Y J H J Taverne, Erasmus University Medical Center, Netherlands
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : The past, present and future of AI in cardiology
Narendra Kumar, HeartbeatsZ Academy, United Kingdom